Showing results (31-40 of 107) with videos related to

Sort By:
Pageof 11
Haematologica|April 12, 2003
Sensitivity to imatinib but low frequency of the TEL/PDGFRbeta fusion protein in chronic myelomonocytic leukemiaRosalind Helen Gunby, Giovanni Cazzaniga, Elena Tassi, et al.
Applied Health Economics and Health Policy|June 7, 2019
Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid LeukemiaCarsten Hirt, Sergio Iannazzo, Silvia Chiroli, et al.
International Journal of Hematology|February 25, 2010
Reduced intensity conditioning prior to allogeneic stem cell transplantation in first complete remission is effective in patients with acute myeloid leukemia and an intermediate-risk karyotypePhilipp G Hemmati, Theis H Terwey, Gero Massenkeil, et al.
Haematologica|December 18, 2009
Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemiaTheo D Kim, Seval Türkmen, Michaela Schwarz, et al.
Frontiers in Oncology|March 7, 2024
Physical exercise recommendations for patients with chronic myeloid leukemia based on individual preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)Lina Hollenbach, Julia Rogahn, Philipp le Coutre, et al.
European Journal of Haematology|October 6, 2009
BCR-ABL positive cells and chronic myeloid leukemia in immune suppressed organ transplant recipientsPhilipp le Coutre, Petra Reinke, Ruth Neuhaus, et al.
Oncology Research and Treatment|June 13, 2023
Variable Outcomes of Hepatitis E Infections in Patients with Hemato-Oncologic DiseasesViktoria Ingwersen, Jörg Hofmann, Marion Muche, et al.
Journal of Clinical and Experimental Hematopathology : JCEH|June 24, 2016
A Rare Case of Acute Myeloid Leukemia with a t(2;3) Chromosomal Translocation Characterized by Thrombophilia and ChemoresistanceCecilia Bozzetti, Seval Türkmen, Ulrich Richter, et al.
Acta Haematologica|February 8, 2014
Effects of Jak2 type 1 inhibitors NVP-BSK805 and NVP-BVB808 on Jak2 mutation-positive and Bcr-Abl-positive cell linesFrauke Ringel, Jaspal Kaeda, Michaela Schwarz, et al.
Acta Haematologica|November 18, 2014
BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatmentNina Rosa Neuendorff, Michaela Schwarz, Philipp Hemmati, et al.
Pageof 11